DOCSLIB.ORG

Histopathology of Prostate Tissue After Vascular-Targeted Photodynamic Therapy for Localized Prostate Cancer Caroline Eymerit-Mo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Histopathology of Prostate Tissue After Vascular-Targeted Photodynamic Therapy for Localized Prostate Cancer Caroline Eymerit-Mo Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer Caroline Eymerit-Morin, Merzouka Zidane, Souhil Lebdai, Stéphane Triau, Abdel Rahmene Azzouzi & Marie- Christine Rousselet Virchows Archiv The European Journal of Pathology ISSN 0945-6317 Volume 463 Number 4 Virchows Arch (2013) 463:547-552 DOI 10.1007/s00428-013-1454-9 1 23 Your article is protected by copyright and all rights are held exclusively by Springer- Verlag Berlin Heidelberg. This e-offprint is for personal use only and shall not be self- archived in electronic repositories. If you wish to self-archive your article, please use the accepted manuscript version for posting on your own website. You may further deposit the accepted manuscript version in any repository, provided it is only made publicly available 12 months after official publication or later and provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”. 1 23 Author's personal copy Virchows Arch (2013) 463:547–552 DOI 10.1007/s00428-013-1454-9 ORIGINAL ARTICLE Histopathology of prostate tissue after vascular-targeted photodynamic therapy for localized prostate cancer Caroline Eymerit-Morin & Merzouka Zidane & Souhil Lebdai & Stéphane Triau & Abdel Rahmene Azzouzi & Marie-Christine Rousselet Received: 5 February 2013 /Revised: 23 April 2013 /Accepted: 8 July 2013 /Published online: 16 August 2013 # Springer-Verlag Berlin Heidelberg 2013 Abstract Low-risk prostate adenocarcinoma is classically Keywords Photodynamic therapy . Photosensitizer . managed either with active surveillance or radical therapy Targeted therapy . WST11 (such as external radiotherapy or radical prostatectomy), but both have significant side effects. Vascular-targeted photo- dynamic therapy (VTP) is a focal therapy proposed as an Introduction alternative approach for localized, low-volume, and low- Gleason score (≤6) carcinomas. We report histological mod- Prostate cancer (PCa) stage and Gleason grade are determi- ifications observed in prostate biopsies of 56 patients, nants of prognosis. With screening of PCa by PSA measure- performed 6 months after VTP using the photosensitizer ment having become the mainstream, many men are diag- TOOKAD® Soluble (WST11) and low-energy laser admin- nosed with low-risk, low-volume, and low-grade PCa. In this istered in the tumor area transperineally by optic fibers. In 53 context, current radical therapies are questioned in terms of patients, we observed sharply demarcated hyaline fibrotic benefit for survival and risk of cancer progression, in view of scars, with or without rare atrophic glands, sometimes re- their significant adverse side effects [1]. Another approach is duced to corpora amylacea surrounded by giant multinuclear active surveillance (AS) which, however, goes along with a macrophages. Mild chronic inflammation, hemosiderin, and significant risk of progression during the surveillance period. coagulative necrosis were also observed. When residual A new approach is the concept of focal therapy which is cancer was present in a treated lobe (17 patients), it was organ-sparing, as selective tumor ablation is the goal. Of the always located outside the scar, most often close to the focal therapy approaches, the most promising are high- prostate capsule, and it showed no therapy-related modifica- intensity-focused ultrasound (HIFU), cryotherapy, and tion. Histopathological interpretation of post-WST11 VTP vascular-targeted photodynamic therapy (VTP) [2–5]. VTP prostate biopsies was straightforward, in contrast with that of is intended for patients with localized PCa, as an alternative prostate biopsies after radio or hormonal therapy, which to AS, as it avoids the risks of morbidity inherent to radical introduces lesions difficult to interpret. VTP resulted in therapy but without compromising life expectancy of the complete ablation of cancer in the targeted area. treated patient [6]. In 1990, a letter to the Lancet reported the application of this minimally invasive procedure in PCa for the treatment of two patients [7]. VTP was further assessed for its tolerance and the dose determined in terms C. Eymerit-Morin : M. Zidane : S. Triau : M.<C. Rousselet of the time of laser illumination with the use of different Cellular and Tissue Pathology Department, LUNAM University, photosensitizers in phase I or phase II studies [8]. At present, CHU University Hospital, Angers, France the TOOKAD® Soluble WST11 (padeliporfin), a chloro- phyll derivative developed by Steba Biotech, is one of the S. Lebdai : A. R. Azzouzi Urology Department, LUNAM University, CHU University photosensitizers of choice [9]. Diagnosis, localization, and Hospital, Angers, France staging of Pca are determined through preoperative prostate biopsies. The photosensitizer is intravenously infused, ab- < * M. C. Rousselet ( ) sorbs light, and transfers energy to oxygen molecules creat- Département de Pathologie Cellulaire et Tissulaire, CHU Angers, 49933 Angers Cedex 9, France ing free oxygen species [10]. Light is introduced by e-mail: [email protected] transperineal optical fibers at the presumed location of the Author's personal copy 548 Virchows Arch (2013) 463:547–552 cancer in the prostate under ultrasound transrectal guidance. Table 1 Inclusion and exclusion criteria for enrollment in the study Damage to vascular endothelium leads to vascular occlusion Inclusion criteria by thrombosis followed by ischemia and necrosis of the Men over 18 years old targeted area. At the cellular level, in vitro studies showed Diagnosed PCa histologically proven on biopsies phototherapy-induced apoptosis [11]. Histological effects of Gleason score ≤3+3 WST11 VTP have been mainly reported in animal models TNM stage up to cT2b-N0/Nx-M0/Mx PSA<10 ng/ml using WST09, the precursor photosensitizer of WST11, or No prior treatment for PCa WST11; early effects such as hemorrhagic necrosis with Eligible for active surveillance inflammation, gland destruction, atrophy, and vascular Exclusion criteria thrombosis have been observed in the treated area, ultimately Contraindication for general anesthesia followed by dense fibrosis [12–14]. In human PCa, the History of viral or alcoholic hepatitis histological lesions induced by WST11 VTP have been History of inflammatory bowel disease or other risk factor for fistula briefly described in review articles focusing on new PCa formation Previous TURP therapies [15, 16]. They appeared similar to what had been Medication with photosensitizing effects reported for WST09: fibrosis without residual cancer cells Anticoagulant drugs but entrapped benign atrophic glands and a very clear de- History of sun hypersensitivity, porphyria marcation between treated areas and the adjacent normal History of renal, hepatic, hematological, or cardiovascular pathology tissue [17]. In the course of phase II trials using WST11 VTP to treat localized PCa, we had the opportunity to study the prostate performed on an automated device (Autostainer, with biopsies of 56 patients before and 6 months after VTP. The Envision-plus revelation kit, Dako) using the cocktail anti- primary aim of our report was to describe the remodeling p504S (monoclonal rabbit antihuman P504S, clone 13H4, effects in prostatic tissue induced by the procedure. The DaKo, 1:200 dilution) and anti p63 (monoclonal mouse anti- secondary aim was to evaluate at 6 months post therapy the human p63 protein, clone 4A4, Dako, 1:100 dilution) with presence of residual cancer and its grade and topography, prior antigen retrieval in EDTA buffer pH 8. notably in the targeted area and in its relation with the Magnetic resonance imaging (MRI) allowed the evalua- prostate capsule. tion of the prostate volume, of any extra-prostatic or nodal extension, and was also necessary to plan the treatment. Material and methods Treatment procedure Population The procedure was performed under general anesthesia The University Hospital of Angers included 56 patients by the same operator. Optical fibers were installed between December 2008 and July 2010 in two open multi- transperineally in the prostate by ultrasound guidance. center prospective phase II trials, with the primary aim to The location and number of fibers depended on the loca- assess tolerance and feasibility of Tookad® Soluble WST11 tion of the tumor according to the results of the biopsies VTP. Patient's consent was obtained, as well as the agree- and MRI. Then, the patients received a 10-min intravenous ment of the Committee of Protection of Persons and the infusion of TOOKAD® Soluble WST11. Subsequently, Ethical Committee. Inclusion and exclusion criteria are listed transillumination of the target zone began with a 753 nm in Table 1. wavelength laser at a fixed power of 150 mW/cm and a fixed energy of 200 J/cm during 22.2 min. This induced Initial diagnosis and staging necrosis of the targeted prostate area. For reasons of secu- rity, the minimal distance between the optical fibers and Initial diagnosis was based on transrectal ultrasound-guided the urethra or the capsule was kept at 5 mm. The patients prostate biopsies of at least 12 cores (six per lobe) performed at were protected from light during the entire procedure and the basis, the middle, and the apex of each hemi gland. for 24 h following treatment. Formalin-fixed paraffin-embedded tissue block of each biopsy
Load more

Recommended publications
  • Improved Postmortem Diagnosis of Taenia Saginata Cysticercosis
    IMPROVED POSTMORTEM DIAGNOSIS OF TAENIA SAGINATA CYSTICERCOSIS A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfilment of the Requirements for the Degree of Masters of Science in the Department of Veterinary Microbiology University of Saskatchewan Saskatoon By WILLIAM BRADLEY SCANDRETT Keywords: Taenia saginata, bovine cysticercosis, immunohistochemistry, histology, validation © Copyright William Bradley Scandrett, July, 2007. All rights reserved. PERMISSION TO USE In presenting this thesis in partial fulfilment of the requirements for a postgraduate degree from the University of Saskatchewan, I agree that the libraries of this university may make it freely available for inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, may be granted by the professor or professors who supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the College in which my thesis work was done. It is understood that any copying or publication or use of this thesis or parts thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition be given to me and to the University of Saskatchewan in any scholarly use which may be made of any material in my thesis. Requests for permission to copy or to make use of material in this thesis in whole or in part should be addressed to: Head of the Department of Veterinary Microbiology University of Saskatchewan Saskatoon, Saskatchewan, S7N 5B4 i ABSTRACT Bovine cysticercosis is a zoonotic disease for which cattle are the intermediate hosts of the human tapeworm Taenia saginata.
    [Show full text]
  • Enophthalmos As the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma
    International Medical Case Reports Journal Dovepress open access to scientific and medical research Open Access Full Text Article CASE SERIES Enophthalmos as the Initial Systemic Finding of Undiagnosed Metastatic Breast Carcinoma This article was published in the following Dove Press journal: International Medical Case Reports Journal Jessica El-Khazen Dupuis Purpose: To report on the importance of detecting and investigating non-traumatic Michael Marchand enophthalmos, which occurred as the first presenting sign of an undiagnosed metastatic Simon Javidi breast carcinoma in two patients with no prior history of neoplasia. Tuan Quynh Tram Nguyen Design: Case series. Observations: The first case consists of a 74-year-old woman with no significant past Department of Ophthalmology, Centre medical history, who presented with a non-traumatic enophthalmos and ptosis of her left eye, Hospitalier de l’Université de Montréal (CHUM), Montreal, QC H2X 3E4, and horizontal diplopia on right-gaze. Imaging revealed an intraconal lesion of her left orbit, Canada with orbital fat atrophy. Transcutaneous anterior orbitotomy was performed for tumor biopsy, and the histopathology study concluded on a diagnosis of orbital metastasis consistent with infiltrative breast carcinoma. Thorough breast imaging and multiple breast biopsies were not able to localize the primary tumor. The second case consists of a 76-year-old woman, with no prior relevant medical history, who presented for progressive enophthalmos and ptosis of her right eye. Imaging revealed an osteolytic lesion of her right frontal bone, and multiple infiltrative lesions implicating both orbits. A biopsy was performed through a transcutaneous anterior orbitotomy and histopathology study lead to a diagnosis of meta­ static lobular breast carcinoma.
    [Show full text]
  • Prostate 1 Prostate
    Prostate 1 Prostate Prostate Male Anatomy Prostate with seminal vesicles and seminal ducts, viewed from in front and above. Latin prostata [1] Gray's subject #263 1251 Artery internal pudendal artery, inferior vesical artery, and middle rectal artery Vein prostatic venous plexus, pudendal plexus, vesicle plexus, internal iliac vein Nerve inferior hypogastric plexus Lymph external iliac lymph nodes, internal iliac lymph nodes, sacral lymph nodes Precursor Endodermic evaginations of the urethra [2] MeSH Prostate [3] Dorlands/Elsevier Prostate The prostate (from Greek προστάτης - prostates, literally "one who stands before", "protector", "guardian"[4] ) is a compound tubuloalveolar exocrine gland of the male reproductive system in most mammals unless they have it removed at birth.[5] [6] In 2002, female paraurethral glands, or Skene's glands, were officially renamed the female prostate by the Federative International Committee on Anatomical Terminology.[7] The prostate differs considerably among species anatomically, chemically, and physiologically. Prostate 2 Function The function of the prostate is to store and secrete a slightly alkaline fluid, milky or white in appearance,[8] that usually constitutes 20-30% of the volume of the semen along with spermatozoa and seminal vesicle fluid. The alkalinity of semen helps neutralize the acidity of the vaginal tract, prolonging the lifespan of sperm. The alkalinization of semen is primarily accomplished through secretion from the seminal vesicles.[9] The prostatic fluid is expelled in the first ejaculate fractions, together with most of the spermatozoa. In comparison with the few spermatozoa expelled together with mainly seminal vesicular fluid, those expelled in prostatic fluid have better motility, longer survival and better protection of the genetic material (DNA).
    [Show full text]
  • Treasures in Archived Histopathology Collections: Preserving the Past for Future Understanding
    Managing Editor, Nancy Klemme Scientific Editor, Vinnie Della Speranza, Vol. XLIII, No. 1 June 2010 MS, HTL(ASCP)HT, MT Treasures in Archived Histopathology Collections: Preserving the Past for (NOAA) National Marine Fisheries Service, and other agencies and Future Understanding academic institutions. The RTLA is a specimen depository and information Doranne Borsay Horowitz, BS, HT(ASCP)1; Esther C. Peters, PhD2; clearinghouse of cases submitted by Inke Sunila, PhD3; Jeffrey C. Wolf, DVM4 researchers from around the world, providing slides of neoplasms1,2 and [email protected] related diseases among reptiles, amphibians, fish, sharks, mollusks, 1US Environmental Protection Agency, Office of Research & Development, National Health & Environmental Effects Research Laboratory, Atlantic Ecology Division, Narragansett, RI arthropods, echinoderms, and coral. 2Department of Environmental Science and Policy, George Mason University, Fairfax, VA These archived collections are valuable 3 State of Connecticut, Department of Agriculture, Bureau of Aquaculture, Milford, CT resources for scientists seeking to 4Experimental Pathology Laboratories, Sterling, VA understand health and disease in diverse species (Fig. 1), for training new aquatic Abstract pathologists, predicting risks from biotic and abiotic stressors (eg, toxicant impacts Extensive collections of histopathology materials from studies of marine and on organisms in multiple locations), freshwater fish, mollusks, crustaceans, echinoderms, and other organisms are archived determining disease status through at the Registry of Tumors in Lower Animals (RTLA), the US Environmental DNA extraction and analysis, supplying Protection Agency (EPA), the National Oceanic and Atmospheric Administration data for historical reconstructions (eg, when a virus first affected a host species), A B IN THIS ISSUE Treasures in Archived Histopathology Collections: Preserving the Past for Future Understanding .
    [Show full text]
  • Ischemic Disease of the Intestine P.H
    7 Ischemic Disease of the Intestine P.H. MacDonald, D.J. Hurlbut and I.T. Beck 1. INTRODUCTION Intestinal ischemia occurs when the delivery of oxygen to the tissue is insuf- ficient to support its metabolic demand. Intestinal oxygen delivery can be impaired by both systemic and local vascular conditions. Atherosclerotic vas- cular disease is often implicated as a factor responsible for intestinal ischemia associated with altered systemic hemodynamics and accounts for the higher incidence of intestinal ischemia in the elderly population. Intestinal tissue blood flow and oxygen delivery may also be impaired as a result of locally mediated events within the intramural circulation of the gut. Such local events have been implicated in intestinal ischemia seen in both young and old patients. The true incidence of intestinal ischemia is unknown. Although overt cases are usually diagnosed correctly, it is generally believed that the condi- tion is often misdiagnosed in those presenting with non-specific abdominal pain. Indeed clinical manifestations of intestinal ischemia are varied and they depend on the site and method of vascular compromise as well as the extent of bowel wall necrosis. 2. CLASSIFICATION OF INTESTINAL ISCHEMIA Many clinicians broadly classify intestinal ischemia into acute or chronic dis- ease. However, because certain acute events may change to a chronic condition, a clear-cut classification of ischemic bowel disease using this two- category system is not always applicable. Since the extent of intestinal ischemia and the pathological consequences depend on the size and the location of the occluded or hypoperfused intestinal blood vessel(s), we find it useful to classi- fy ischemic bowel disease according to the size and type of the vessel(s) that are hypoperfused or occluded (Figure 1).
    [Show full text]
  • A Histological Analysis of Burn Wound Progression
    A HISTOLOGICAL ANALYSIS OF BURN WOUND PROGRESSION Raymond Thai Quan Bachelor of Biomedical Science Submitted in fulfilment of the requirements for the degree of Master of Philosophy School of Biomedical Sciences Faculty of Health Queensland University of Technology 2021 Keywords Anti-Fibrinogen, burn depth, burn marker, burn wound conversion, burn wound progression, damage marker, fibrin, formalin fixed; paraffin embedded, haematoxylin and eosin, histology, immunofluorescence, immunohistochemistry, MSB fibrin stain, pathology, porcine burn model, scald, skin, structural damage A Histological Analysis of Burn Wound Progression i Abstract Burn wound progression is the phenomenon in which burns progress in depth following the initial injury. This can cause superficial partial burns, which would normally heal within two weeks, to progress into deep-dermal partial thickness or full thickness burns, resulting in delayed healing and poorer long-term outcomes. In the literature, histological burn wound analysis involves the detection of multiple burn damage markers including collagen denaturation, cellular necrosis, cellular apoptosis, and vascular pathologies. A variety of histochemical and immunohistochemical stains have been utilised to detect these markers. In this study, Haematoxylin and eosin (H&E), Verhoeff’s Van Gieson (VVG), Gomori’s Trichrome (GT), Martius Scarlet Blue (MSB) and a fibrinogen antibody were optimised and evaluated for their ability to detect burn markers within a porcine scald burn model. H&E was effective for observing cellular necrosis, collagen denaturation and vascular pathologies. Collagen denaturation was also detected by VVG and GT with the additional detection of elastin fibres and vascular pathologies, respectively. MSB staining provided detection of collagen denaturation and vascular pathologies with the additional detection of fibrin deposition.
    [Show full text]
  • The C-Cells: Current Concepts on Normal Histology and Hyperplasia
    THE C-CELLS: CURRENT CONCEPTS ON NORMAL HISTOLOGY AND HYPERPLASIA ANGELA BORDA*, NICOLE BERGER**, M. TURCU***, M. AL JARADI**, SORANA VEREŞ**** *Histology Department, University of Medicine and Pharmacy, Târgu Mureş; **Pathology Department, Lyon Sud Hospital; ***Pathology Department, University of Medicine and Pharmacy, Târgu Mureş; ****”Petru Maior” University, Târgu Mureş Summary. We describe the current concepts on the embryology, normal morphology and immunohistochemistry of a minor cell population of the thyroid, the C-cells. We also try to make delineation between the normal number of the C-cells and C-cell hyperplasia. The two types of C-cell hyperplasia, physiologic and neoplastic are defined and characterized from morphologic and genetic point of view. Their relation with thyroid pathology, especially with medullary thyroid carcinoma is discussed. Key words: C-cell, C-cell hyperplasia, medullary thyroid carcinoma. INTRODUCTION Two distinct cell populations may be found in the thyroid parenchyma: the follicular cells, so far the most numerous, endodermally derived and synthesizing thyroglobulin, and the C-cells, a minor cell population, also known in the past as parafollicular cells, very different from the former in origin, morphologic appearance and function. The C-cells were first described in animals (rats and dogs). In the human thyroid, Pearse, using silver stain methods, recognized them only in 1966. He suggested that these cells contain calcitonin and coined their name: the C-cells. His finding was confirmed by the development of the immunohistochemistry and the anti-calcitonin antibody, demonstrating the presence of this hormone in the C-cells cytoplasm (Bussolati et al., 1967). By that time, it was also demonstrated that medullary carcinoma, a distinct form of thyroid carcinoma described by Hazard (1959), consisted of C-cells (Williams et al., 1989).
    [Show full text]